Neonatal screening for citrullinaemia

European Journal of Pediatrics

Volumn 162, Issue 6, 2003, Pages 417-420

  Sander, Johannes ^a   Janzen, Nils ^a   Sander, Stefanie ^a   Steuerwald, Ulrike ^a   Das, Anibh M ^b   Scholl, Sabine ^b   Trefz, Friedrich K ^c   Koch, Hans Georg ^d   Häberle, Johannes ^d   Korall, Herbert ^e   Marquardt, Iris ^f   Korenke, Christoph ^f  

^a Screening Labor   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Klinikum Reutlingen   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e Zentrum Stoffwechseldiagnostik R   (Germany)

^f KLINIKUM OLDENBURG   (Germany)

Author keywords

Citrullinaemia; Inborn errors of metabolism; Neonatal screening; Persistent citrullinaemia; Tandem mass spectrometry

Indexed keywords

ARGININOSUCCINATE LYASE; CITRULLINE;

ARTICLE; BLOOD SAMPLING; CITRULLINEMIA; CLINICAL ARTICLE; DISEASE SEVERITY; ENZYME DEFICIENCY; HUMAN; HYPERAMMONEMIA; LABORATORY DIAGNOSIS; NEWBORN; NEWBORN SCREENING; ONSET AGE; PILOT STUDY; PRIORITY JOURNAL; SYMPTOMATOLOGY; TANDEM MASS SPECTROMETRY;

EID: 0038620281     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-003-1177-z     Document Type: Article

References (14)

1. Brusilow SW, Horwich AL (2001) Urea cycle enzymes. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1907-1963
2. Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Hofman LF (1993) Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem 39: 66-71
3. Häberle J, Pauli S, Linnebank M, Kleijer WJ, Bakker HD, Wanders RJA, Harms E, Koch HG (2002) Structure of the human argininosuccinate synthetase gene and an improved system for molecular diagnostics in patients with classical and mild citrullinemia. Hum Genet 110: 327-333
4. Jacobs R (1997) Genetic screening - uses, potential abuses and ethical issues. Occup Med 47: 367-370
5. Lumley J (1991) Trials and the evaluation of screening programs. In: Wilcken B, Webster D (eds) Neonatal screening in the nineties. Proceedings of the 8th International Screening Symposium, Leura, Australia pp 11-17
6. Maestri NE, Clissold DB, Brusilow SW (1995) Long-term survival of patients with argininosuccinate synthetase deficiency. J Pediatr 127: 929-935
7. McMurray WC, Rathbun JC, Mohyuddin F, Koegler SJ (1963) Citrullinuria. Pediatrics 32: 347-349
8. Saheki T, Kobayashi Inove I (1987) Hereditary disorders of the urea cycle in man: biochemical and molecular approaches. Rev Physiol Biochem Pharmacol 108: 21-68
9. Sander J, Janzen N, Sander S, Melchiors U, Steuerwald U (2000) Tandemmassenspektrometrie, Beitrag zum Neugeborenenscreening auf angeborene Störungen des Stoffwechsels. Monatsschr Kinderheilkd 148: 771-777
10. Saudubray J-M, Touati G, Delonlay P, Jouvet P, Narcy C, Laurent J, Rabier D, Kamoun P, Jan D, Revillon Y (1999) Liver transplantation in urea cycle disorders. Eur J Pediatr 158[Suppl 2]: S55-S59
11. Tokatli A, Coskun T, Ötzalp I (1998) Citrullinemia, Clinical experience with 23 cases. Turk J Pediatr 40: 185-193
12. Wallmann C (1998) Newborn genetic screening. Neonatal Network 17: 55-60
13. Wick H, Bachmann C, Baumgartner R, Brechbühler T, Colombo JP, Wiesmann U, Mihatsch MJ, Ohnacker H (1973) Variants of citrullinemia. Arch Dis Child 48: 636-641
14. Wilson JMG, Jungner G (1968) Principles and practice of screening for disease. WHO Public Health Papers 34: 26-35